# interferon beta

Type: Product

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/interferon-beta
Canonical HTML page: https://getbiobrief.com/entity/interferon-beta

## Recent coverage (1 stories)

### Biosidus Partners with Mubadala Bio to Bring 4 Biologic Therapies to UAE Market
2026-07-27 05:00:58 · Sentiment: Positive · Impact: 6/10 · Sources: 1

Biosidus, a Latin American biotech, signed a licensing deal with Mubadala Bio at BIO 2026 to introduce four biologic therapies—including epoetin alfa and filgrastim—into the UAE via DiabTec. The move advances local pharma manufacturing and expands Biosidus' global footprint.
Full story: https://getbiobrief.com/story/biosidus-mubadala-bio-uae-partnership

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.